News

The American Journal of Managed Care3d
Smartphone-Powered CKD Screening Yields 2.5-Fold Increase in Testing, Early Diagnoses
Smartphone-based home screening significantly boosts chronic kidney disease (CKD) diagnosis and follow-up care, enhancing ...
The Manila Times4d
SF Holding Launched H-share Equity Issuance and Concurrent Zero Coupon Convertible Bonds Offering
S.F. Holding Co., Ltd. (002352.SZ; 06936.HK, 'SF Holding', 'SF' or the 'the Company') announced a USD 376 million H-share equity placement and concurrent USD 376 million offering of 363-day ...
BMJ4d
Glycated haemoglobin A1c is associated with low-grade albuminuria in Chinese adults - BMJ Open
Background and objective Diabetes is a strong risk factor for cardiovascular diseases, whereas few studies have investigated simultaneously the associations of glycated haemoglobin A1c (HbA1c), ...
BioCity’s SC0062 gains NMPA breakthrough therapy designation
The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted BioCity's ...
Vietnam Investment Review on MSN5d
BioCity s SC0062 wins breakthrough status for kidney disease treatment
BioCity Biopharma ("BioCity") announced today that the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation (BTD) to ...
Healio6d
Lorundrostat lowers BP in adults with hypertension, CKD: Topline data
Mineralys Therapeutics announced positive topline results from its phase 2 Explore-CKD trial, in which lorundrostat lowered ...